AS03-adjuvanted H1N1 pandemic influenza vaccine [clinicaltrials_resource:f2b94ded55484c3453d7377dfdf989ee]
intervention [clinicaltrials_vocabulary:intervention]
AS03-adjuvanted H1N1 pandemic influenza vaccine [clinicaltrials_resource:f2b94ded55484c3453d7377dfdf989ee]
Bio2RDF identifier
f2b94ded55484c3453d7377dfdf989ee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f2b94ded55484c3453d7377dfdf989ee
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
One dose constitutes 0.5mL of suspended vaccine via the intramuscular route.
intervention name [clinicaltrials_vocabulary:intervention-name]
AS03-adjuvanted H1N1 pandemic influenza vaccine
other name [clinicaltrials_vocabulary:other-name]
Arepanrix(R)
identifier
clinicaltrials_resource:f2b94ded55484c3453d7377dfdf989ee
title
AS03-adjuvanted H1N1 pandemic influenza vaccine
@en
type
label
AS03-adjuvanted H1N1 pandemic ...... 94ded55484c3453d7377dfdf989ee]
@en